Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice
J Extra Corpor Technol, 51 4 (2019) 221-226
Published online: 2019-12-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Combined Antithrombin and Heparin Supplementation to Blood for Restoring Heparin Responsiveness After Andexanet Alfa Exposure: An In Vitro Model
Amir L. Butt, Hisako Okada, Kofi B. Vandyck, Nana Toyoda, Shinobu Itagaki, Kenneth E. Stewart and Kenichi A. TanakaeJHaem 7 (1) (2026)
https://doi.org/10.1002/jha2.70234
Risk Factor Analysis of Inadequate Heparin Response in Pediatric Cardiac Surgery
Sirintip Swangwong, Kirsten Odegard, Gregory Matte, Meena Nathan, Sitaram Emani, Sirisha Emani and Koichi YukiJournal of Cardiothoracic and Vascular Anesthesia (2026)
https://doi.org/10.1053/j.jvca.2026.04.024
Activated Clotting Time Measured by Hemochron Signature Elite in Adult Cardiac Surgery: Implications for Clinical Practice
Filippo Maria Russo, Andrea Artoni, Mauro Cotza, Giacomo Veronese, Stefano Cenci, Mariantonia Villano, Nora Di Tomasso, Giovanna Pedrazzini, Maria Abbattista, Cristina Novembrino, Martina Anguissola, Rosanna Cardani, Flora Peyvandi, Marco Ranucci and Giacomo GrasselliJournal of Cardiothoracic and Vascular Anesthesia 39 (10) 2615 (2025)
https://doi.org/10.1053/j.jvca.2025.05.031
719 (2025)
https://doi.org/10.1016/B978-1-4557-0599-3.00069-7
ACT targets during atrial fibrillation ablation
Thomas A. Boyle, Adrian M. Petzl and David S. FrankelHeart Rhythm 22 (7) e259 (2025)
https://doi.org/10.1016/j.hrthm.2024.12.023
283 (2025)
https://doi.org/10.1007/978-3-031-91163-7_23
Activated Clotting Time Measurement in Cardiac Surgery: An Infinite Game
Daniel Bolliger and Kenichi A. TanakaJournal of Cardiothoracic and Vascular Anesthesia 39 (10) 2623 (2025)
https://doi.org/10.1053/j.jvca.2025.06.036
A Case of Antiphospholipid Syndrome Underwent Cardiac Surgery Performed Using Coagulation Management by Measuring Heparin Concentration during Extracorporeal Circulation
Riko Umeta, Tomohiro Nakajima, Yutaka Iba, Itaru Hosaka, Akihito Okawa, Naomi Yasuda, Tsuyoshi Shibata, Junji Nakazawa and Nobuyoshi KawaharadaJapanese Journal of Cardiovascular Surgery 52 (1) 9 (2023)
https://doi.org/10.4326/jjcvs.52.9
Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron® Response and Hemochron® Signature Elite
Roland F Hoffmann, Sandra Horsten, Massimo A Mariani and Adrianus J de VriesPerfusion 38 (2) 285 (2023)
https://doi.org/10.1177/02676591211049316
How We Would Treat Our Own Hypoplastic Left Heart Syndrome Neonate for Stage 1 Surgery
Katherine L. Zaleski, Eleonore Valencia, Gregory S. Matte, Aditya K. Kaza and Viviane G. NasrJournal of Cardiothoracic and Vascular Anesthesia 37 (4) 504 (2023)
https://doi.org/10.1053/j.jvca.2023.01.003
Hybrid Left Heart Bypass Circuit for Repair of the Descending Aorta in an 8-kg Williams Syndrome Patient
Gregory S. Matte, William L. Regan, Kevin R. Connor, Dima G. Daaboul, David M. Hoganson and Luis G. QuinonezThe Journal of ExtraCorporeal Technology 53 (3) 186 (2021)
https://doi.org/10.1051/ject/202153186
Publication Ethics
Raymond K. WongThe Journal of ExtraCorporeal Technology 51 (4) 193 (2019)
https://doi.org/10.1051/ject/201951193